Effects of once-weekly semaglutide vs once-daily canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 randomised controlled clinical trial

AIMS/HYPOTHESIS: Intra-abdominal or visceral obesity is associated with insulin resistance and an increased risk for cardiovascular disease. This study aimed to compare the effects of semaglutide 1.0 mg and canagliflozin 300 mg on body composition in a subset of participants from the SUSTAIN 8 Phase...

Descripción completa

Detalles Bibliográficos
Autores principales: McCrimmon, Rory J., Catarig, Andrei-Mircea, Frias, Juan P., Lausvig, Nanna L., le Roux, Carel W., Thielke, Desirée, Lingvay, Ildiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997246/
https://www.ncbi.nlm.nih.gov/pubmed/31897524
http://dx.doi.org/10.1007/s00125-019-05065-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997246/
https://www.ncbi.nlm.nih.gov/pubmed/31897524
http://dx.doi.org/10.1007/s00125-019-05065-8

Ejemplares similares